These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16499995

  • 1. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [Abstract] [Full Text] [Related]

  • 2. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H, Ekstrøm PO, Ryberg D, Skaug V, Andreassen T, Stangeland L, Haugen A, Zienolddiny S.
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [Abstract] [Full Text] [Related]

  • 3. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y, McDermott MP, Ahrendt SA.
    Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626
    [Abstract] [Full Text] [Related]

  • 4. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT.
    Carcinogenesis; 2005 Oct 01; 26(10):1770-3. PubMed ID: 15905205
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T.
    Int J Oncol; 1998 Mar 01; 12(3):577-81. PubMed ID: 9472095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.
    Oncogene; 1997 Dec 11; 15(24):2951-8. PubMed ID: 9416838
    [Abstract] [Full Text] [Related]

  • 13. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG.
    Cancer Lett; 2008 Feb 08; 259(2):177-85. PubMed ID: 18037232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP, Wong RH, Wu TC, Cheng YW, Chen CY, Lee H.
    Ann Surg Oncol; 2009 Jul 08; 16(7):1918-24. PubMed ID: 19434453
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY.
    Lung Cancer; 2006 Apr 08; 52(1):15-20. PubMed ID: 16476505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.